LitAlert ~~ GeneLit.com

    • Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study.
    • van Barele M, Rieborn A, Heemskerk-Gerritsen BAM, Obdeijn IM, Koppert LB, Loo CE, Tollenaar RAEM, Ausems MGEM, van de Beek I, Berger LPV, de Boer M, van Hest LP, Kets CM, Rookus M; Hebon, Schmidt MK, Jager A, Hooning MJ.
    • Breast Cancer Res Treat. 2022 May 4. doi: 10.1007/s10549-022-06608-1. Epub ahead of print.
    • The great majority of homologous recombination repair-deficient tumors are accounted for by established causes.
    • Polak P, Štancl P, Hamel N, Foulkes WD, Karlic R.
    • Front Genet. 2022 May 3;12:852159. doi: 10.3389/fgene.2022.852159.
    • Alterations in homologous recombination repair genes in prostate cancer brain metastases.
    • Rodriguez-Calero A, Gallon J, Akhoundova D, Maletti S, Ferguson A, Cyrta J, Amstutz U, Garofoli A, Paradiso V, Tomlins SA, Hewer E, Genitsch V, Fleischmann A, Vassella E, Rushing EJ, Grobholz R, Fischer I, Jochum W, Cathomas G, Osunkoya AO, Bubendorf L, Moch H, Thalmann G, Ng CKY, Gillessen S, Piscuoglio S, Rubin MA.
    • Nat Commun. 2022 May 3;13(1):2400. doi: 10.1038/s41467-022-30003-5.
    • Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark.
    • Fonnesbech Hjorth C, Damkier P, Bjerregaard Stage T, Feddersen S, Hamilton-Dutoit S, Rørth M, Ejlertsen B, Lee Lash T, Patrick Ahern T, Toft Sørensen H, Cronin-Fenton D.
    • Breast Cancer Res Treat. 2022 Apr 30. doi: 10.1007/s10549-022-06596-2. Epub ahead of print.
    • Rational design, synthesis and biological evaluation of dual PARP-1/2 and TNKS1/2 inhibitors for cancer therapy.
    • Xu Y, Wu H, Huang L, Zhai B, Li X, Xu S, Wu X, Zhu Q, Xu Q.
    • Eur J Med Chem. 2022 Apr 27;237:114417. doi: 10.1016/j.ejmech.2022.114417. Epub ahead of print.